ABT-737, BH3 mimetic Bcl-xL, Bcl-2 and Bcl-w inhibitor from Abcam

Product Specs
ItemABT-737, BH3 mimetic Bcl-xL, Bcl-2 and Bcl-w inhibitor
CompanyAbcam
Price Supplier Page View Company Product Page
Catalog Numberab141336
Quantity10 MG
Typeinhibitor

Add to Compare List

Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

Company Profile

Website: http://www.abcam.com

(1) Cell Survival Is Regulated via SOX9/BCL2L1 Axis in HCT-116 Colorectal Cancer Cell LineJournal of OncologyApril 29, 2020Erik Lizárraga-Verdugo et al.24-wells plate and incubated at 37°C for 24 h, and then the fresh medium containing 5 μM ABT737 (Abcam, ab141336), a BH3 mimetic, was added for 48 h to inhibit BCL2L1 function. According to the recommended protocol,

(2) The ZIKA Virus Delays Cell Death Through the Anti-Apoptotic Bcl-2 Family ProteinsCellsOctober 29, 2019Jonathan Turpin, Etienne Frumence, Philippe Desprès, Wildriss Viranaicken, Pascale Krejbich-Trototreagents were from Sigma Aldrich (Humeau, La Chapelle-Sur-Erdre, France) except when indicated. ABT-737 (ab141336) was purchased from Abcam (Cambridge, UK). 2.2. Plaque Forming Assay Viral titers were determined

(3) Secreted Heat Shock Protein 90α Attenuated the Effect of Anticancer Drugs in Small-Cell Lung Cancer Cells Through AKT/GSK3β/β-Catenin SignalingCancer control : journal of the Moffitt Cancer CenterJanuary 1, 2018Du Y, Wu J, Luo L.Canada). Doxorubicin (DOX, #25316-40-9, LC Laboratories, Woburn, Massachusetts) and ABT-737 (ABT, Abcam, ab141336) were dissolved according to the manufacturer’s instructions. Ak strain transforming (AKT) inhibitor

Be the First to Write a Review!

ABT-737, BH3 mimetic Bcl-xL, Bcl-2 and Bcl-w inhibitor from Abcam

Abcam

Citations (3)

Reviews

ABT-737, BH3 mimetic Bcl-xL, Bcl-2 and Bcl-w inhibitor from Abcam

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map